Advent International has announced the new Board of directors and management team for Suven Pharma. Suven Pharma will be led by a management team comprising Annaswamy Vaidheesh, executive chairman, V Prasada Raju, managing director and Sudhir Kumar Singh, chief executive officer to drive Suven Pharma's global growth as it aims to become a top CDMO player. Annaswamy Vaidheesh, a pharmaceutical veteran with over 35 years of experience, including as MD of GSK India, and earlier was with J&J Asia Pacific in senior regional leadership positions.

Prasada Raju, has over 29 years of experience in the pharmaceutical industry, with leadership roles at Cohance Life Sciences, Granules India Ltd. and Dr Reddy's Laboratories. Dr Sudhir Kumar Singh, a reputed industry veteran who was the ex-COO at Aragen Life Sciences for more than 10 years, joins as the CEO of Suven Pharma. In addition to the new management team, Suven has appointed an Advisory Council with Venkateswarlu Jasti, founder, Suven Pharma and Suven Lifesciences; Abhijit Mukherjee, Ex-COO of Dr Reddy's; James Mullen, ex-president and CEO of Patheon and Biogen; and Stefan Stoffel, ex-COO of Lonza.

In terms of the Board of directors, along with Vaidheesh and Raju, Pankaj Patwari, managing director at Advent, will also join the team. Suven will also have three independent directors joining the board K.G Ananthakrishnan, ex-MD MSD India and ex-director general of OPPI, and chairman of PNB; Matangi Gowrishankar, ex-BP global head of Capability Development, and Vinod Rao, ex-global treasurer and head of Investor Relations for Diageo.Advent plans to foster Suven's capabilities to help it strive towards becoming one of the leading companies in the CDMO space globally.